SABS

SAB BIOTHERAPEUTICS INC

Healthcare | Micro Cap

-$0.17

EPS Forecast

$0.25

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-07-01

Proximilar's AI forecasts

EPS Forecast:

-$0.17

Revenue Forecast:

$0.25

EPS Surprise Forecast:

-$0.013

Revenue Surprise Forecast:

-$0

Post-release price volatility - High

Post-release Overnight Move:

±9.1%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

45%

Probability of beating revenue consensus:

47%

Probability of beating both EPS & revs consensus:

27%

Probability of missing both EPS & revs consensus:

35%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-2

Beta (β)

Forward Looking Beta (β):

0.90

Earnings volatility

EPS standard deviation:

$0.18

Revenue standard deviation:

$5

As % of share price:

4.75% EXTREME UNCERTAINTY

As % of market cap:

2.64% HIGH

Confidence intervals and percentiles

EPS 95th %ile:

$0.04

Revenue 95th %ile:

$6

EPS 75th %ile:

-$0.12

Revenue 75th %ile:

$2

EPS 25th %ile:

-$0.23

Revenue 25th %ile:

-$1

EPS 5th %ile:

-$0.40

Revenue 5th %ile:

-$5

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

66% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$75

Bid-ask per Share:

$0.03